Skip to main content
Show full summary

Lord Roberts of Llandudno to ask Her Majesty's Government what assessment they have made of reports that a COVID-19 placenta-based cell therapy, developed in Israel, has had a 100 per cent survival rate during clinical trials.  HL3216

Question HL3216: tabled on 21 April 2020 and due for answer by 5 May 2020

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

To ask Her Majesty's Government what assessment they have made of reports that a COVID-19 placenta-based cell therapy, developed in Israel, has had a 100 per cent survival rate during clinical trials.
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.